Author:
Huertas D,Soler M,Moreto J,Villanueva A,Martinez A,Vidal A,Charlton M,Moffat D,Patel S,McDermott J,Owen J,Brotherton D,Krige D,Cuthill S,Esteller M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference48 articles.
1. Berdasco M, Esteller M . (2010). Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 19: 698–711.
2. Bryan J, Jabbour E, Prescott H, Garcia-Manero G, Issa JP, Kantarjian H . (2010). Current and future management options for myelodysplastic syndromes. Drugs 70: 1381–1394.
3. Carpinelli P, Moll J . (2008). Aurora kinases and their inhibitors: more than one target and one drug. Adv Exp Med Biol 610: 54–73.
4. Cheng A, Balczon R, Zuo Z, Koons JS, Walsh AH, Honkanen RE . (1998). Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity. Cancer Res 58: 3611–3619.
5. Chopra P, Sethi G, Dastidar SG, Ray A . (2010). Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert Opin Investig Drugs 19: 27–43.
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献